Glucose-insulin-potassium for acute myocardial infarction: remarkable results from a new prospective, randomized trial.
Apstein
C S
CS
D002314:Cardioplegic Solutions / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy*; D011188:Potassium / Q000627:therapeutic use; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D015912:Thrombolytic Therapy
D002314:Cardioplegic Solutions; D007328:Insulin; C030396:glucose-insulin-potassium cardioplegic solution; D005947:Glucose; D011188:Potassium